By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences will spend $15 million to expand its pharmacogenomics web resource containing data on genetic variation and drug response, NIGMS said Tuesday.

The Pharmacogenomics Knowledge Base (PharmGKB) is a hub for international researchers that catalogs the links between human genetic variation and drug responses, and analyzes and integrates pharmacogenomic data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.